Skip to content

P3 Health Partners Inc. (PIII) stock: revenue, earnings & dividend

P3 Health Partners Inc. (PIII, Nasdaq): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener PIII · Nasdaq Gesundheitswesen US-NV

Key figures

Fiscal year
2025
Revenue
1.46 bn $
Revenue growth
-2.8 %
Revenue growth 5y (p.a.)
24.3 %
Net income
-147.95 m $
Net margin
-10.1 %
Operating margin
-18.5 %
Earnings per share (diluted)
-45.26 $
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
657 m $
Equity
-155.23 m $
Equity ratio
-23.6 %
Return on equity
–
Cash
25 m $
Operating cash flow
-91.24 m $
Free cash flow
–
Shares outstanding
–

History

Revenue by fiscal year

2019 145 m $
2020 491 m $
2021 579 m $
2022 1.05 bn $
2023 1.27 bn $
2024 1.5 bn $
2025 1.46 bn $

Net income by fiscal year

2019 -41.97 m $
2020 -31.41 m $
2021 -24.81 m $
2022 -270.13 m $
2023 -57.77 m $
2024 -135.85 m $
2025 -147.95 m $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20251.46 bn $-147.95 m $-45.26 $–-91.24 m $
20241.5 bn $-135.85 m $-54.06 $–-110.13 m $
20231.27 bn $-57.77 m $-0.63 $–-76.03 m $
20221.05 bn $-270.13 m $-6.50 $–-126.02 m $
2021579 m $-24.81 m $––-1.59 m $
2020491 m $-31.41 m $––-24.6 m $
2019145 m $-41.97 m $––-28.29 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)